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Abstract
There is discrepancy amongst organizations and the medical community whether bimanual
pelvic examinations should be performed in asymptomatic women for routine screening. The
purpose of this literature review was to determine whether bimanual pelvic examinations are
beneficial for screening for ovarian cancer in comparison to no screening. In addition, research
was conducted to see if healthcare providers’ professional beliefs align with the evidence and
national recommendations, to determine women’s thoughts and beliefs regarding pelvic
examinations, and if bimanual pelvic exams are not a valid screening tool for ovarian cancer,
what are other screening methods available. Throughout reviewing peer reviewed articles and
high-quality evidence, it was found that bimanual pelvic exams have low sensitivity for
screening, which is not ideal due to false positives; however, several researchers still feel this is
an important screening tool. Also, many providers still feel the pelvic exam is beneficial when
performed annually on asymptomatic women as part of a well-woman exam and continue to
perform them routinely in the office. Research also shows that the majority of women do not feel
uncomfortable or pain during a pelvic exam and the majority wish to continue having them
performed on a regular basis. Combinations of different screening methods such as pelvic
examination with serum CA-125 annually and serum CA-125 with transvaginal ultrasound
annually were found to be effective in screening for ovarian cancer in asymptomatic women.

Keywords: bimanual pelvic examination, pelvic exam, ovarian cancer screening, CA-125,
transvaginal ultrasounds, gynecological screening, adnexal mass, asymptomatic women
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Introduction
An asymptomatic 25-year-old female presents to the clinic for her annual well-woman
exam; she had a Papanicolaou (Pap) performed last year which was negative for intraepithelial
lesions or malignancy. An asymptomatic 68-year-old female presents in the clinic for her annual
Medicare wellness exam; she has a history of entirely negative Pap results performed on a
regular basis and stopped Pap screenings when she was 65 years old. The Papanicolaou test has
been well proven to save numerous lives by screening for cervical cancer. Until recently, a Pap
screening was performed with a pelvic examination for visualization of the vagina and cervix
and a bimanual examination of the uterus, adnexa, and ovaries as part of an annual well-woman
visit. Then, in 2013, the American College of Obstetricians and Gynecologists (ACOG) changed
the recommendation of performing Pap screenings from annually to every three years in women
ages 21 to 65 years, or every five years if co-screening for human papillomavirus (HPV) in
women ages 30 to 65 years (American College of Obstetricians and Gynecologists, 2018).
Unfortunately, the benefits, harms, or recommendations of performing regular pelvic exams
when a Pap is not needed are not as clearly defined as the cervical cancer screening guidelines.
The two cases above are excellent examples of this. Neither woman are in need of a Pap
screening for their annual well-woman exam, however, the question remains, should a routine
pelvic examination be performed in otherwise asymptomatic women?
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Statement of the Problem
Since the frequency of Pap tests has decreased, there has been much debate within the
medical community on the frequency of pelvic examinations or if they are even beneficial at all
in asymptomatic adult women. Some feel that not performing pelvic exams on an annual basis as
part of a well-woman exam may cause the potential to delay ovarian cancer diagnosis or other
diseases of the female genitalia. Others feel that screening with annual pelvic exams in
asymptomatic women is not beneficial and gives women a false sense of security or may lead to
unnecessary additional testing or surgery.
In about 70 percent of cases, ovarian cancer is diagnosed late, usually beyond the
possibly of a cure (Chagas, E. & Brazil, A., 2016). Most women with tumors of the ovaries or
fallopian tubes are asymptomatic and approximately 75 percent of ovarian cancer diagnoses are
metastatic with poor survival rates even with treatment (Adonakis, Paraskevaidis, Tsiga,
Seferiadis, & Lolis, 2016). Ovarian cancer that is found only in the ovary and has not
metastasized has a five-year survival rate of 92 percent compared to a five-year survival rate of
30 percent with metastatic ovarian cancer (Jemal, Siegel, Ward, Hao, Xu, & Thun, 2009). There
are more deaths from ovarian cancer than the total of uterine and cervical cancer deaths
combined (Matteson, Gunderson, & Richardson, 2017). Therefore, a screening tool with high
sensitivity is important to detect these findings early.
Statement of the Research Questions
In asymptomatic women who receive Pap screenings every three or five years, are pelvic
exams beneficial for ovarian cancer screening in comparison to no screening? Do healthcare
provider’s professional beliefs align with the evidence and national recommendations? What are
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women’s thoughts and beliefs regarding pelvic examinations? If pelvic exams are not beneficial,
what other screening methods are available for ovarian cancer?
Research Methods
Searches from Pubmed, American College of Obstetricians and Gynecologists’ website,
and CINAHL revealed multiple studies related to the research questions. Additional articles were
found by using references lists. Studies were limited to English publications, high quality
evidence, and published after 2008 except for several studies which are older than 2008 due to
lack of recent studies on the subject.
My first Pubmed search was ovarian cancer screening which resulted in 31,800 articles. I
narrowed this down by excluding all except for clinical studies which resulted in 886. I
researched further by adding with pelvic exam to my original search title and received seven
studies. Five of these were not relevant because they included studies focusing on endometriosis,
birth control, and symptomatic women. Other Pubmed searches were bimanual pelvic exam
which resulted in 46 articles and 42 were excluded because they did not pertain specifically to
the research questions, value to bimanual pelvic exam which resulted in eight articles and three
articles were previously found by other searches, effect of screening on ovarian cancer mortality
with 321 results and found two articles recommended based on citations that matched the search,
and bimanual pelvic exam with 46 results narrowed down to three by searching just clinical
studies. I also searched Pubmed with the heading gynecological screening which resulted in
13,364 articles; this was narrowed down to 581 by only looking at clinical studies and narrowed
further by adding for cancer to the original title to have 62 clinical study results. The Pubmed
search women’s thoughts on pelvic exam resulted in eight articles and patients’ beliefs on pelvic
exams resulted in 38.
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A Pubmed search titled pelvic exam as a screening tool gave 77 articles and 75 were
excluded due to most articles not pertaining to asymptomatic women and most being literature
reviews. One article was found entitled Screening pelvic examination in adult women: a clinical
practice guideline from the American College of Physicians. Two high quality studies were
found from sources used in this article, however the studies were from 1995 and 1996. Due to
lack of recent studies, these older studies are included in this literature review. In addition, an
article titled A combined approach for the early detection of ovarian cancer in asymptomatic
women cited a study from 1993 and was used in this review due to lack of current research.
I searched the American College of Obstetricians and Gynecologists’ website by using
pelvic examination and obtained 82 results, primarily consisting of recommendations and
guidelines for screening. I narrowed these down by only using articles with guidelines that
pertained directly to my PICO question. One study conducted in 2000 was found that was used
in creating the committee opinion on well-woman visits titled Accuracy of the pelvic
examination in detecting adnexal masses.
I also searched CINAHL with the key words being pelvic examinations and cancer
prevention and found 67 articles. I again excluded articles if they did not relate directly to
asymptomatic women, pelvic examinations, or ovarian cancer screening which left me with five
articles that were relevant, however, three of these were also found in Pubmed. The two
additional articles found in CINAHL were used also.

8
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Literature Review
Bimanual Pelvic Examination for Ovarian Cancer Screening
A case-control study published in 2007 compared medical visit frequency, pelvic
examination, and the type of health care provider to ovarian cancer risk (Abenhaim, TitusErnstoff, & Cramer, 2007). This study was performed by conducting interviews with women
during a five-year period in New Hampshire and eastern Massachusetts. There was a total of 691
cases of ovarian cancer or borderline cancer that were found by state registries and agreed to
participate and 721 age and location matched women without ovarian cancer were found to
participate by driver license registries. All participants were interviewed and asked questions
regarding the frequency of medical visits, frequency of pelvic examinations, and type of
healthcare provider used during the five-year period. The control group used for this study had at
least one medical visit and one pelvic examination per year performed by a gynecologist or
obstetrician and were compared to those who did not have these factors.
Abenhaim, Titus-Ernstoff, and Cramer (2007) found that women with ovarian cancer
were significantly less likely to have an annual medical visit and pelvic exam, but there was not a
significant difference in which type of health care provider that the women saw. In addition,
there was a significant difference between the controls and the specific outcomes measured in
this study. It was found that 6.1 percent of ovarian cancer cases did not have a medical visit in
the five-year study compared to 2.4 percent in the non-cancer group. Also, 9.4 percent of the
case group did not have a pelvic examination in the five years compared to 2.5 percent in the
control group and 4.9 percent of the cases did not have a regular health care provider in
comparison to just 1.5 percent in the non-cancer group. Other results of the study are shown in
table 1. Therefore, the conclusion was drawn that women, especially post menopause, who do
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not have pelvic examinations, medical visits, or a regular health care provider are at an increased
risk of ovarian cancer and regular medical visits and pelvic examinations should be encouraged.
As a side note, it was also found with this study that cases of ovarian cancer were more likely to
be nulliparous, unmarried, post-menopausal, have a family history of breast or ovarian cancer,
and less likely to have used oral contraceptives, hormone replacement therapy, or had a tubal
ligation compared to age matched controls.
One limitation to this study is that it was a case-control study and not all cases and
controls contacted agreed to participate which could skew results (Abenhaim, Titus-Ernstoff, &
Cramer, 2007). Also, selection bias could be a limitation due to the fact that this study was not
able to include all the cases of ovarian cancer in the entire New England region, only two states
were included, and the information gathered may not be able to be generalized to other regions.
Also, there were other participants who qualified for the study, but their physicians would not
give permission for the study to contact these women. One strength of this study is the
researchers separated premenopausal and postmenopausal information and results, which is
important because the risk of ovarian cancer in each group is different.

BIMANUAL PELVIC EXAMINATIONS

11

Table 1
The Risk of Ovarian Cancer
All participants
No. of
cases
n • 668

No.of
controls
n • 721

◄7◄
56

550

34

Variable

Premenopau.sal women

Adjusted' OR
(95% Cl)

No. of
cases
n • 310

No. of
controls
n • 337

203

233

37

32

Adjusted' OR
(95%CI)

Postmenopausal women
No. of
cases
n • 358

No.of
controls
n • J84

271

317

19

22

Adjusted' OR
(95%CI)

No. of medical
visits
<!: 5

54

1.0
1.2 (0.8 1.8)

1.0
1.5 (0. 9 2.5)

1.0
1.0 (0.5 1.9)

1-2

96

100

1.1 (0.8-1.6)

55

59

1.1 (0.7-1.7)

41

◄1

0

◄1

17

2.8 (1.5-5.0)

15

13

1.2 (0.5-2.7)

26

4

7.7 (2.6-23.0)

0'

◄1

17

2. ◄

15

13

1.1 (0.4-2.8)

26

4

5.6 (1. 8-17.3)

<!: 5

◄52

537

3-4

60

64

(1.3-4.7)

1.2 (0.7·1.9)

No. of pelvic
examinations
198

253

254

284

1.1 (0.7-1.6)

1.0

◄1

1.0
1.5 (0.9· 2.4)

19

2S

0.7 (0.4-1.4)

1.0
0.8 (0.5-1.3)

1-2

91

102

1.0 (0.7-1.4)

48

36
43

1.4 (0.8-2.2)

43

59'

0

63

18

3.9 (2.2-6.9)

23

5

5.0 (1.8-14.2)

13

3.3 (1. 7-6.5)

O'

63

18

2.9 (1.6 5.3)

23

5

3.3 (1.1 9.9)

40
40

13

2.3 (1.1 4.7)

OB/GYN

151

167

1.0

104

112

1.0

◄7

5S

1.0

Other
physician

Health care
provider

463

519

0.9 (0. 7 1.2)

181

199

0.8 (0.5-1.1)

282

320

Non-physician

19

24

0.8 (0.4 1.6)

12

17

0.6 (0.3 1.3)

7

T

1.1(0.71.7)
1.4 (0.4 4.3)

No provider

33

11

2.7 (1.3-5.7)

12

9

0.8 (0.3-2. 1)

21

2

12.5 (2.7-57.6)

No provider'

33

11

2.2 (1.0-4.8)

12

9

0.8 (0.3-2.4)

21

2

7.4 (1.5-36.1)

Note: OR • odds rauo. Cl • confidfflce- interval, 08/GYN • obstetrician•~olotist.
"Adjusted for age, parity, et.hnk background, education, marital status, religion and family history of breast or ovarian cancer.
tAdjusted additionally f« ~
il'l!, body mass index, hormone replacement therapy, oral contraceptive pills, over-the-counter medications. prescription medications,
multivitamins, talc for genital hygiene, tubal ligation and ovarian cystectomy.

Note. Adapted from “Ovarian cancer risk in relation to medical visits, pelvic examinations, and
type of health care provider”, by H. A. Abenhaim, L. Titus-Ernstoff, and D. W. Cramer, 2007,
Canadian Medical Association Journal, 176(7), p. 941-947. Copyright: 2007 by the Canadian
Medical Association or its licensors.
The Prostate, Lung, Colorectal and Ovarian cancer screening (PLCO) trial is a
randomized controlled study of 154,900 women conducted to assess the sensitivity and
specificity of bimanual ovarian palpation for ovarian cancer screening (Doroudi, Kramer, &
Pinsky, 2016). This study had two groups, a control group which had regular annual wellness
exams with bimanual ovarian palpation and an intervention group consisting of annual CA-125
testing and transvaginal ultrasound. The sensitivity of ovarian palpitation for ovarian cancer
screening was found to be 5.1 percent and the specificity was 99.0 percent. No cases of ovarian
cancer were detected by bimanual examination and the bimanual examination was removed from
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the study five years into the trial due to the lack of findings. The PLCO trial found that bimanual
palpation of ovaries is not beneficial for screening for ovarian cancer in asymptomatic women
due to low sensitivity.
A 1995 Australian study was conducted by Grover and Quinn to determine the value of
pelvic examinations in screening for ovarian abnormalities. This study recruited 2,623
asymptomatic women, with an average age of 51 years old, and all underwent both a bimanual
pelvic examination by an unspecified type of provider and the measurement of CA-125 serum
levels. Pelvic exams were considered abnormal if the uterus was an irregular shape or
approximated to be larger than six weeks gestation. In addition, the ovaries and fallopian tubes
were considered abnormal if there was a mass felt or if an ovary felt enlarged. CA-125
measurements of 35 U/mL or greater were considered abnormal. Women had further evaluation
with a transvaginal ultrasound if there were positive findings of the adnexa on bimanual exam or
if CA-125 was elevated. If the transvaginal ultrasound results were abnormal, surgery was
performed for further evaluation. Results of the bimanual exam showed an enlarged uterus or
uterus with fibroids in 12.9 percent of participants and abnormal findings of the adnexa in 1.5
percent. The other results of the bimanual examination findings are in table 2.
In addition, results can be seen in table 3 of the 40 women who went on to have a
transvaginal ultrasound performed (Grover & Quinn, 1995). 22 percent of the women were
found by transvaginal ultrasound to have ovarian disease and 32.5 percent had an abnormal
uterus with fibroids.
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Table 2
Findings on Bimanual Examination
Premenopausal

-

""-:-.,·:.-:--_,:.- ...

Perimenopausal

• (n= 1121)

._...•

Ut~tu·s
Mormal size
Bulky*
FilJroid'
% Bulky or fibroid
Absent
Abnormal ·adnexa

Postmenopausal

(n =38~ - ...--, -:;-

829
188
37

238
61
16

2 1%
67
20(1 .8%)

25%
69
4 (1%)

Total

(n =1 118)

(n= 2623)

915
29
8
4%
166

1982
278
61
13%
302
40(1.5%)

16 (1 .4%)

•R,,gular shape btJt > six weeks' gestati°" size.
'irregular shape due 10 subsewsal fibroids.

Note. Adapted from “Is there any value in bimanual pelvic examination as a screening test?”, by
S. R. Grover and M. A. Quinn, 1995, The Medical Journal of Australia, 162(17) p. 408-410.
Copyright: 1995 by the Department of Obstetrics and Gynecology, University of Melbourne,
Royal Women’s Hospital.
Table 3
Findings of transvaginal ultrasound
Premenopausal
(n= 1121)
Number of women(%)
Normal pelvis
F,oroids
Ovanan disease

20(1.8%)
10
6

4*

Perimenopausal
(n=384)

Postmenopausal
(n = 1118)

4(1%)

16 (1 .4%)

2
1
1'

6
6

4,

Total (%)
(n=2623)
40( 1.5%)
18(45%)

13(32.5%)
9(22%)

' Oermoid (1), endomelriosis (2) . simple 2 5cm cyst (1)
Enta,ge<1 CNary, not confirmed at diagnostic laparoscopy.
•Benign cyst (2). cystadenoma (1). bilateral fibromas (1)

1

Note. Adapted from “Is there any value in bimanual pelvic examination as a screening test?” by
S. R. Grover and M. A. Quinn, 1995, The Medical Journal of Australia, 162(17) p. 408-410.
Copyright: 1995 by the Department of Obstetrics and Gynecology, University of Melbourne,
Royal Women’s Hospital.
Nine of the 40 women who were found to have abnormal adnexa by pelvic exam had
benign ovarian disease (Grover & Quinn, 1995). Therefore, the positive predictive value of
finding an ovarian mass by bimanual examination is calculated to be 22.5 percent based on these
results. There were four false negatives of this study where women originally had a negative
pelvic examination, but adnexal masses were found by ultrasound. In addition, it is not known if

BIMANUAL PELVIC EXAMINATIONS

14

more false negatives were not found during this study due to not performing ultrasounds on all
women in the study.
Throughout this study, no cases of ovarian cancer were found originally (Grover &
Quinn, 1995). However, the study followed up on all participants by sending surveys one year
later and 83 percent responded. One woman who responded to the follow up survey did have
ovarian cancer. At initial screening while participating in the study, she had a normal pelvic
exam and elevated CA-125 therefore she went on to have a transvaginal ultrasound which was
negative. Her cancer was found due to rising CA-125 levels after the study. Therefore, the
positive predictive value for finding ovarian cancer with pelvic examinations was zero and for
benign ovarian findings was 22 percent. Due to relatively common benign adnexal findings at
1.5 percent of the population and low probability of ovarian cancer predicting that 20 percent
would undergo unnecessary surgery for benign findings, the authors of this study do not
recommend routine pelvic examinations for ovarian cancer screening nor as part of a wellwoman visit.
One limitation of the study by Grover and Quinn (1995) is that it was performed in
Australia at one hospital and results could vary in different regions or countries. Also, all the
participants were volunteers; this was not a randomized controlled study and therefore, women
and providers knew the reason for the pelvic examinations which could influence results,
possibly with increased findings on pelvic exams due to providers feeling as if they should not
miss something. There was not mention as to how many or what type of provider was
performing the pelvic examinations, nor with the technicians or interpretation of the ultrasounds.
Padilla, Radosevich, and Milad in 2000 conducted a study to determine how accurate the
pelvic examination is in finding adnexal masses. This was a prospective cohort study, occurred
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from March 1, 1997 to March 15, 1998, and was performed at Prentice Women’s Hospital of
Northwestern Memorial Hospital (Padilla, Radosevich, & Milad, 2000). 140 women who were
scheduled to have a laparoscopy or laparotomy consented to have pelvic examinations performed
prior to their procedures. Conditions were standardized as much as possible by performing pelvic
exams while the women were under general anesthesia for anxiety and fear to not be factors in
the study and Foley catheters were placed so that bladder size did not interfere with the
examination.
The examiners performing the pelvic examinations included 52 gynecologists, 30
gynecology residents, and 40 third- and fourth-year medical students (Padilla, Radosevich, &
Milad, 2000). Examiners did not know the patients’ diagnoses or what surgery was being
performed after the pelvic examinations, and each examiner performed no more than nine
percent of the total pelvic examinations for this study. Each examiner was instructed to record
any findings of the pelvic exam particularly of the uterus, adnexa, and rectovaginal area in regard
to size, position, and any masses. Then, the surgeons recorded actual findings of the procedures
and these results were compared to the pelvic exam findings from the examiners being studied.
In this study, left and right adnexa results were kept separate, five cm or more was
considered a mass, and a uterus was considered enlarged when it was the size of eight weeks’
gestation or larger (Padilla, Radosevich, & Milad, 2000). The Youden J statistic was also
calculated, which is a combination of the sensitivity and specificity minus one meaning a
calculation of one being a perfect test.
There was a total of 361 pelvic examinations performed by 127 physicians and when the
pelvic exam results were compared to surgical findings, sensitivity was low at 26 percent,
specificity was high at an average of 87 percent, and the positive predictive value was an average
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of 0.47 for findings on pelvic exams (Padilla, Radosevich, & Milad, 2000). The study calculated
that an adnexal mass was found only eight percent of the time by pelvic examination regardless
of the type of provider. The other results of the study can be seen in table 4. The authors do not
advise to not perform pelvic examinations, they instead state it is important to know the
limitations of pelvic examinations.
Huge strengths of this study are that all patients were under general anesthesia, in the
lithotomy position, and bladders emptied via Foley placement making the setting as controlled as
possible. Also, the providers performing the pelvic examinations did not know the reason they
were being performed or what surgery was taking place afterwards. Limitations in this study
were found to be obesity and uterine enlargement in detecting ovarian masses (Padilla,
Radosevich, & Milad, 2000).
Table 4
Detection of Adnexal Masses by Type of Examiner

Left adnexa
Attending physicians (11 • 127)
Residents (11

~

138)

Students (11 • 97)
Right adnexa
Attending physicians (11 • 127)
Residents (11 = 138)
Studen ts (n • 97)

Youdcn/
statistic

Positive
predictiv<'
value

5<-nsitivity

Specificity

0.33
(0.20, 0.46)
0.36
(0.23, 0.49)
0.23
(0.11,0.41)

0.88
(0.79, 0.94)
0.91
(0.82, 0.96)
0.8'7
(0.75, 0.94)

0.21
(0.06, 0.36)
0.27
(0.12, 0.42)
0.10
(-0.07, 0.26)

0.21
(0.10, 0.39)
0.28
(0.14, 0.47)
0.15
(0.0.t,039)

0.79
(0.69, 0.86)
0.87
(0.78, 0.92)
0.92
(0.83, 0.97)

0.00
(-0.16, 0.16)
0.15
(-0.02, 032)
0.07
(- 0.1.0,0.24)

0.26
(0.12, 0.47)
0.39
(0.19, 0.59)
0.33
(0.03, 0.64)

Likelihood ra lio
Abnormal

Normal

0.64
(G.45,0.83)
0.69
(OSI, 0.87)

2.8

0.8

4.0

0.7

o.so

1.7

0.9

1.0

1.0

2.1

0.8

1.9

0.9

(0.26, 0.75)

Data are presented as a proportion (95% confidence interval).

Note. Adapted from “Accuracy of the pelvic examination in detecting adnexal masses”, by L. A.
Padilla, D. M. Radosevich, and M. P. Milad, 2000, Obstetrics & Gynecology, 96(4), p. 593-598.
Copyright: 2000 by The American College of Obstetricians and Gynecologists.
The American College of Physicians (ACP) performed a systematic review to determine
their guidelines for pelvic examination screenings from studies between the years 1946 and 2014
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(Qaseem, Humphrey, Harris, Starkey, & Denberg, 2014). Based off this review, the ACP has
given a strong recommendation determined by moderate-quality evidence to not perform pelvic
examination screenings in asymptomatic women and advise that the pelvic examination should
be taken out of the well-woman visit entirely. In addition, they advise during a Pap test for
cervical cancer screening that a pelvic exam should not be performed and should only include
the cervical samples for the Pap test and a visual inspection.
ACP’s moderate quality evidence to advise against performing pelvic examinations
include low sensitivity of pelvic examination findings and increased costs (Qaseem, Humphrey,
Harris, Starkey, & Denberg, 2014). It is estimated that pelvic examinations performed in the
clinic alone costs $2.6 billion in additional healthcare costs per year which ACP has determined
to be unnecessary. This cost does not include further exploration testing, insurance, and medical
visits from false positives found on bimanual examinations. Additional harms found by the
systematic review include pain, fear, and anxiety for women, urinary tract infections or dysuria,
false hope, and unnecessary additional testing and associated harm. Therefore, the ACP
determined harms of bimanual ovarian palpation are vastly greater than the benefits.
A limitation to the ACP review is that the recommendation to not perform bimanual
exams is based off what the ACP deems as “moderate quality evidence” which is not the best
evidence for guidelines (Qaseem, Humphrey, Harris, Starkey, & Denberg, 2014, p. 67). Also, the
ACP did not review any studies based on provider differences in performing pelvic exams or
harms that can come from pelvic exams.
A study performed by Steolinga, Huirne, Heymans, Reekers, Ankum, and Hehenkamp
(2014) compared the accuracy of bimanual examination in determining the size of uterine
fibroids. The study included 177 women with an average age of 45 years old. A hysterectomy
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was being performed in 89 of the women and 88 were having a uterine artery embolization due
to fibroids (Steolinga et al., 2014). Prior to the procedures, the uterine size was estimated by a
bimanual examination and by a transvaginal ultrasound. Bimanual examinations were performed
by either senior residents or gynecologists. Fibroid uterine volume (FUV) was measured in
gestational weeks and converted to uterine volume in grams. The actual size of the uterus was
determined at the hysterectomy or by magnetic resonance imaging (MRI) in those having the
uterine artery embolization. After all the studies and procedures, the level of agreement between
the bimanual exam and ultrasound compared to actual size was determined and a score was
given. Scores greater than 0.75 means that there was excellent matching of size, scores between
0.4 to 0.75 means there was a satisfactory accuracy of estimation, and scores less than 0.4 means
a poor determinant of estimating uterine size. Bimanual pelvic examinations compared with MRI
results has a score of 0.63 (satisfactory accuracy) with uterine volume less than 233, 0.28 (poor
accuracy) with a volume between 233 and 747, and 0.24 (poor accuracy) with a volume greater
than 747. Bimanual exams compared with exact size determined from surgery were 0.62, 0.37,
and 0.71 respectfully. Also, ultrasound measurement results versus exact size were 0.59, 0.44,
and 0.56 respectfully.
This study determined that both the bimanual examination and transvaginal ultrasounds
are poor at estimating uterine size when the uterus is between 233 and 747 grams (Steolinga et.
Al., 2014). Both tended to underestimate the uterine size. This study also found that the bimanual
exam and ultrasound were better and had satisfactory results at predicting size with larger uterus
greater than 747 grams or smaller than 233 grams in comparison to a uterus between these two
sizes.
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Some limitations of this study include the MRI is not the gold standard for measuring
uterine size and may have error as well, measurements from the MRI and ultrasound were
converted to grams using a formula that assumes the uterus is a spheroid shape and fibroids
would distort this shape making it difficult to properly estimate the size with a standardized
formula, and the position of the uterus or location of the fibroids were not taken into account.
Providers’ Beliefs on Pelvic Examinations
A study published in 2013 was conducted by surveying obstetricians and gynecologists
from 2010 to 2011 to understand when and why pelvic examinations are performed and how
important practitioners feel they are (Henderson, Harper, Gutin, Saraiya, Chapman, & Sawaya,
2013). The participants for this study were found by using the American Medical Association’s
Physician Masterfile with the goal of finding at least 500 participants. 1,020 providers were
randomly selected to receive a mailed survey and 521 of them were able to participate. On the
survey, the obstetricians and gynecologists were given four different female patient vignettes
(figure 5) and were asked to determine if they would perform a pelvic exam. In all these
vignettes, the women were asymptomatic and did not need a Pap test. They were then asked to
rate the importance of different components of a female examination with one of these
components being bimanual pelvic exams. For each question, participants were to choose from
the following responses: very important, moderately important, a little important, and not
important. Lastly, the participants were asked how important it was to perform bimanual pelvic
exams in asymptomatic women in different conditions or screenings and were able to give the
same responses as above to find other reasons for performing pelvic exams. In addition, the
physician practice setting, and provider’s age, gender, and race were recorded for interpretation.
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Overall, when looking at all four vignettes that were presented to the participants, an
average of 95 percent said that they would perform a pelvic examination on these patients with
an average of 57.5 percent believe it is very important (Henderson, et. Al., 2013). Almost all the
providers would even perform a bimanual exam on the vignette of a patient who had a complete
hysterectomy and bilateral oophorectomy. Additional results of the rating of importance in each
of the four vignettes is presented in figure 6. Over 75 percent of providers felt the bimanual
pelvic exam is very important or moderately important for ovarian cancer screening. The
majority felt they are very important or moderately important to find benign uterine fibroids or
ovarian cysts. Reasons that the majority perform bimanual pelvic exams include “reassure
patient of health, accommodate patient expectations, and adhere to standard medical practice”
(Henderson et al., 2013, p. 109). Compensation was the least significant reason to perform them.
The entirety of the results of reasons to perform bimanual pelvic exams can be seen in figure 7. It
was also noticed during this survey that if physicians had their own practice, they tended to
believe pelvic examinations were more important.
One limitation to this study is that the survey was limited to only obstetricians and
gynecologists participating and did not include other providers (Henderson et al., 2013). Another
limitation is the survey responders were younger than the nonresponsive providers and younger
providers may interpret the vignettes differently or have different practice beliefs than the older
providers, however, specific age ranges were not provided. Also, the majority (89.6%) of
providers who participated belong to the American College of Obstetricians and Gynecologists
(ACOG), which has different recommendations regarding pelvic exams compared to the ACP. In
addition, this study is based off surveys with patient case scenarios and did not study what is
practiced on real patients in the providers’ clinics. A strength to this study is participants saw an
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average of 85 patients per week which it can be assumed the study included established, full time
providers.
Patient 1

Patient 2

An 18-y-old woman presents to you for a routine health visit. She became
sexually active 1 mo ago. She has no history of dysplasia, is not
immunocompromised, has no symptoms, and is not pregnant.
A 35-y-old woman with no new sexual partners n last 5 y presents for a routine
healU1 visit. Sile has had 3 Gu1iseculive 11u1111al a mual Pilj) lesls wilil you, last ur

which was 1 y ago. She has no history of dysplasia, is not immunocompromised,
has no symptoms, and is not pregnant.
Patient 3

A 55-y-old woman presents to you for a routine health visit. Her cervix and
ovaries were removed last year at time of hysterectomy for symptomatic
fibroids. She has no history of dysplasia, is not immunocompromised, and has
no symptoms.

Patient 4

Healthy 70-y-old woman presents to you for a routine health visit. She has had
annual Pap tests with normal findings for past 30 y. She has not been sexually
active for last 10 y. She has no history of dysplasia, is not immunocompromised,
and has no symptoms.

Fu each vignette, respolllefllS - e insttu:led, 'Fu this patient, please irdicale >melher you wrud perfurm each of
folklwilg"; and, ' Fu ltis paliefll, please ildicale )(>Jr opinM about imporlllnee ol each ol lolklwing.• Clinical semces listed
were: (I} Pac, lest, (2) numan paplllomavtrus tesi. (3) VISUal lnSpecllon of extematgenNalla. (4) speclitm examtnallOO, (~)
bimanual peMc ex.11Tlinatiln without rectal examination. and (6) bimanlal petvic e>amination with rectal examination.

Figure 5. Patient Vignettes
Note. Adapted from “Routine bimanual pelvic examinations: Practices and beliefs of US
obstetrician-gynecologists”, by J. T. Henderson, C. C. Harper, S. Gutin, M. Saraiya, J. Chapman,
and G. F. Sawaya, 2013, American Journal of Obstetrics & Gynecology, 208, p. 109.e1-7.
Copyright: 2013 by Mosby, Inc.
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Figure 6. Thoughts of Practitioners on Pelvic Examinations
Note. Adapted from “Routine bimanual pelvic examinations: Practices and beliefs of US
obstetrician-gynecologists”, by J. T. Henderson, C. C. Harper, S. Gutin, M. Saraiya, J. Chapman,
and G. F. Sawaya, 2013, American Journal of Obstetrics & Gynecology, 208, p. 109.e1-7.
Copyright: 2013 by Mosby, Inc.

BIMANUAL PELVIC EXAMINATIONS

22
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Figure 7. Reasons for Bimanual Pelvic Examinations in Asymptomatic Women by Importance
Note. Adapted from “Routine bimanual pelvic examinations: Practices and beliefs of US
obstetrician-gynecologists”, by J. T. Henderson, C. C. Harper, S. Gutin, M. Saraiya, J. Chapman,
and G. F. Sawaya, 2013, American Journal of Obstetrics & Gynecology, 208, p. 109.e1-7.
Copyright: 2013 by Mosby, Inc.
Another study performed also by J. T. Henderson was conducted among obstetricians and
gynecologists across the United States by a mailed survey from May 2010 to January 2011 to
determine thoughts on when pelvic exams should be performed and possible repercussions of
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performing pelvic exams every three years instead of annually (Henderson, Yu, Harper, &
Sawaya, 2014). A sample of 1,020 obstetricians and gynecologists were randomly selected from
the American Medical Association’s Physician Masterfile and 521 responded to participate.
Participants were asked how important a pelvic exam was before being sexually active, during
reproductive years, and after menopause with the response choices of very important,
moderately important, a little important, and not important (Henderson, Yu, Harper, & Sawaya,
2014, p. 49). They were then asked to predict negative outcomes of performing gynecological
exams every three years instead of annually.
The majority of physicians (94 %) felt annual pelvic examinations are either very
important or moderately important in reproductive years and 89 percent thought the same after
menopause (Henderson, Yu, Harper, & Sawaya, 2014). Additional results of importance ratings
can be seen in figure 8. There were several possible negative outcomes of performing
gynecologic exams every three years instead of annually that were weighed heavily during the
survey. 74 percent of responders felt this would reduce patient health and wellbeing, 78 percent
estimate a decrease in patient satisfaction,74 percent felt this would decrease the ability to obtain
contraception, and 93 percent felt there would be a decrease in clinic productivity. It was
observed that younger providers and female providers were less likely to report a decrease in
patient satisfaction.
Some strengths of this study include surveying providers from across the United States to
give a wide variety to provider population, a high reply volume from the mailed survey, a wide
range participants’ ages, and the average number of patients seen by each responder was 85 per
week (Henderson, Yu, Harper, & Sawaya, 2014). One limitation to this study is it was a mailed
survey, therefore, providers who responded may have different beliefs than those who opted to
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not respond. However, they stated their response rate is similar to response rates of other mailed
surveys. Another limitation could be participants were asked to answer based off future
predictions and this may not be the reality of the future. Also, most responders were ACOG
members. Another limitation is this study was conducted by the primary author as the prior study
discussed, and these two studies by the same author have the same number of participants and
same timeframe; therefore, it can be assumed these were conducted together on the same
participants and validity is questioned having these as two separate studies.
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Figure 8. Importance of Pelvic Examinations Based on Stages of Life
Note. Adapted from “U.S. clinicians’ perspectives on less frequent routine gynecologic
examinations” by J. T. Henderson, J. M. Yu, C. C. Harper, and G. F. Sawaya, 2014, Preventative
Medicine, 62, p. 49-53. Copyright: 2014 by Elsevier Inc.
Stewart, Thistlethwaite, and Evans (2008) conducted a survey with in person interviews
of general practitioners (GPs) to determine what GPs practice in their clinics for pelvic
examinations due to ACP guidelines recommending to not perform them on a regular basis.
Requests to participate in the study were sent to 87 GPs and 27 agreed to participate with 18
being female providers and nine males with an average of 19 years of experience (the minimum
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was five years of experience) (Stewart, Thistlethwaite, & Evans, 2008). Questions for the
interview were established by investigators and research professionals based on literature
reviews of pelvic exams.
The results of this study showed that most participants still perform regular pelvic
examinations even though they are advised otherwise from the ACP guidelines (Stewart,
Thistlethwaite, & Evans, 2008). Most also discussed the importance of talking with patients
prior to performing them and discussing the pros and cons to the patients. One provider
(participant number 27) stated “patient awareness that cancer of the cervix isn’t the only
gynecological problem there is, (is important)” (Stewart, Thistlethwaite, & Evans, 2008, p. 494).
Some reasons that providers listed as to why they continue regular pelvic exam screenings
include finding abnormalities of the female genitalia, legal consequences of missing a diagnosis
if not performing them, to assess tone of the pelvic floor muscles, reassurance for the provider
and the patient, for completeness of a well-woman examination, and being taught to perform
them annually. Even though most still practice performing regular pelvic exams because of the
points discussed above, several of the providers often wonder if pelvic examinations are valuable
due to studies and literature reviews. Participant number 11 stated, “I do pelvic examination for
completeness, but I am not sure it is such a reliable test” (Stewart, Thistlethwaite, & Evans,
2008, p. 495). Several disadvantages to performing annual pelvic exams were found during the
study which include possibly giving false reassurance to patients and providers, not finding a
diagnosis during a pelvic exam, time limitations as pelvic exams take up more time leaving less
time to discuss other health concerns, and chaperones are encouraged for the exams, but this also
requires additional time and staffing.
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Limitations to this study include a low response rate at 31 percent of GPs possibly due to
lack of time and the study was conducted in an urban setting in Australia which possibly cannot
be generalized to other communities or countries (Stewart, Thistlethwaite, & Evans, 2008).
Also, this was a very small sample size to perform a study on. In addition, the factor of cost was
not discussed at all in this study which is important to note when considering pelvic examination
screenings.
A study was conducted by Stormo, Cooper, Hawkins, and Saraiya (2012) via surveys sent
to different types of providers to determine beliefs regarding pelvic examinations, how often they
were performed, and why they were performed. A total of 1,250 obstetricians and gynecologists,
family medicine providers, and internal medicine providers participated in the study and were
asked by survey to either answer agree, disagree, or don’t know to the following questions: “A
pelvic exam includes a bimanual exam, a pelvic exam includes a rectovaginal exam, a pelvic
exam is a useful screening test for gynecologic cancers among asymptomatic women, and a
pelvic examination should be performed at the time of a routine Pap test” (Stormo, Cooper,
Hawkins, & Saraiya, 2012, p. 415). The survey then asked, “for which cancer, if any, do you
think pelvic examinations are effective in screening asymptomatic women in the average-risk
population” and options to choose from were “vulvar, uterine, ovarian, cervical, vaginal, none of
these” and multiple answers were allowed (Stormo, Cooper, Hawkins, & Saraiya, 2012, p. 415).
Lastly, they were asked to answer “always, most of the time, some of the time, rarely, or never”
to how often they performed bimanual exams “to screen for ovarian cancer, as part of a wellwoman visit, to screen for other gynecologic cancers, to screen for sexually transmitted
infections, and as a requirement for starting oral or other hormonal contraception” (Stormo,
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Cooper, Hawkins, & Saraiya, 2012, p. 415). Pelvic examinations were considered routine in this
study if physicians answered always or most of the time.
A total of 83.6 percent of obstetricians and gynecologists, 78.8 percent of internists, and
74.9 percent of family medicine providers felt that pelvic examinations are useful as a screening
tool (p < 0.001) (Stormo, Cooper, Hawkins, & Saraiya, 2012). Out of the 250 obstetricians and
gynecologists, 98.4 percent thought a pelvic exam should be a routine part of a well-woman visit
compared with 89.5 percent of the 609 family practitioners, and 54 percent of the 391 internal
medicine providers (p < 0.001). 92 percent of obstetricians and gynecologists, 55.2 percent of
family practitioners, and 29.7 percent of internists felt bimanual exams should be routinely
performed to screen for ovarian cancer. Also, most obstetricians and gynecologists (70%) felt
that using pelvic examinations for ovarian cancer screening is effective, whereas 48.8 percent of
family practice physicians and 50.4 percent of internists felt this way. Out of all practitioners
participating in this study, 81.3 percent felt that pelvic exams should be performed routinely with
Pap tests. It was also noticed during this study that those performing pelvic exams were more
likely to be female and have practiced for over 20 years.
One limitation to this study is that quota sampling was used, and the information gathered
from this study may not be a good representation of all physician practices and beliefs. Also,
requirements of local practice were not studied or if performing pelvic examinations is different
depending on the age of the patient.
Stormo, Hawkins, Cooper, and Saraiya (2011) conducted a study to determine when a
provider feels pelvic exams are needed for screening. Participants were found by the 2009
DocStyles survey of US doctors and were randomly selected to receive an email survey.
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The providers were asked to answer how often they performed pelvic examinations in
specific scenarios given (Stormo, Hawkins, Cooper, & Saraiya, 2011). The different scenarios
can be seen in table 9 below. They were asked to respond from the choices of always, most of the
time, some of the time, rarely, or never. Only the responses of always or most of the time were
considered as being routine use of pelvic exams. They analyzed responses from 250 obstetricians
and gynecologists, 391 internists, and 609 family providers. The average age of all providers was
45.3 years. 98.4 percent of obstetricians and gynecologists and 89.5 percent of family
practitioners felt that pelvic exams should be used routinely in a well-woman exam as opposed to
only 54.0 percent of internists (p < 0.001). Also, 95.2 percent of the obstetrician and
gynecologist group thought that pelvic exams should be used routinely to screen for ovarian
cancer in comparison to just over half of the family practitioners and only 29.7 percent of
internists. Other results of the study can also be seen in table 9 below.
This study shows that although pelvic examinations are not recommended by most
guidelines for routine screening, most providers across different specialties still perform them
primarily as part of well-woman exams (Stormo, Hawkins, Cooper, & Saraiya, 2011). The
authors of this study felt the 98 percent of obstetricians and gynecologists performing pelvic
examinations for screening is concerning because 98 percent of the positive screenings are false
positives which can lead to unnecessary further testing and anxiety.
Two limitations of this study are providers qualified to participate if they saw at least 10
patients per week which is a very low volume and they had to practice for at least three years in
which, for example, a provider with 30 years of experience versus three years of experience are
probable to have different practicing beliefs (Stormo, Hawkins, Cooper, & Saraiya, 2011). Also,
70 percent of the providers were male, and 74 percent were Caucasian which can influence
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results of a survey greatly. A strength is that they used data collected over the entire US which
includes many different populations and settings.
Table 9
Routine Use of Pelvic Exams by Scenario and Type of Provider
Physicians, No. (%)
Reported Use
As part of a "well-woman exam"
To screen for ovarian cancer
To screen for other gynecologic cancers
To screen for STls
As a requirement for hormonal contraception

FP/GPs
(n=609)

Internists
(n=391)

OB/GYNs
(n=250)

P Value

545 (89.5)
336 (55.2)
41 4 (68.0)
444 (72.9)
412 (67.7)

211 (54.0)
116 (29.7)
161 (41.2)
152 (38.9)
157 (40.2)

246 (98.4)
238 (95.2)
240 (96.0)
229 (91.6)
179 (71.6)

<.001
<.001
<.001
<.001
<.001

Abbreviations: FP/GPs, family/general practitioners; 08/GYNs, obstetrician/gynecologists; STls, sexually transmitted infections.
aPearson';( asymmetrical 2-sided tests were used to compare percentages across specialties. "Routine use" is defined as performing pelvic examinations for
ach stated purpose "always" or "most of the time."

Note. Adapted from “The pelvic examination as a screening tool: Practices of US physicians”, by
A. R. Stormo, N. A. Hawkins, C. P. Cooper, and M. Saraiya, 2011, Archives of Internal
Medicine, 171(22), p. 2053-2054. Copyright: 2011 by the American Medical Association.
Women’s Beliefs and Thoughts on Pelvic Examinations
A cross-sectional survey was conducted in 2015 to determine women’s attitudes and
beliefs regarding pelvic examinations due to the change in ACP guidelines in 2014 which
advises against performing pelvic examinations in asymptomatic women (Kling et al., 2017).
The surveys were offered to nonpregnant women ages 21 years and older in two outpatient Mayo
clinics, one located in Arizona and the other in Rochester, Minnesota. Survey questions were
written based off literature review, were self-administered, and were multiple choice. The
women were first asked questions regarding their beliefs on pelvic examinations; then they were
given the new ACP guidelines on pelvic examinations. After given the ACP guidelines, the
women were then asked additional questions to see if their beliefs on pelvic examinations had
changed.
Results of the survey showed that 53.9 percent of women believe that pelvic
examinations should be performed before knowing the ACP guidelines and 49.0 percent of these
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had annual pelvic exams performed (Kling et al., 2017). It was found that 61.4 percent of the
women participating had not known about the ACP recommendations and after reviewing the
guidelines, there was a significant difference in thoughts; 34.9 percent said that they would
continue having pelvic exams (p < 0.001). Also, 92.4 percent of women in the survey had pelvic
examinations performed on a regular basis either annually or every two, three, four, or five years,
and after the ACP recommendations were reviewed, this number decreased to 86.7 percent
stating they plan to continue receiving pelvic exams on a regular basis at some interval.
One limitation to this study is that information was self-reported and past medical history
was not confirmed by looking at a medical chart (Kling et al., 2017). Another limitation is the
population studied was from a higher social class which may interfere with generalization to
other populations. There was not a racial diversity of the women studied as 87 percent were
Caucasian thus making it difficult to generalize as well.
The ACP systematic review conducted by Qaseem, Humphrey, Harris, Starkey, and
Denberg (2014) found that overweight women were more likely to feel uncomfortable during a
pelvic examination than women at a normal weight and that fear and pain were greater in women
with a history of sexual abuse than those without.
Other Ovarian Cancer Screening Methods
A study by Adonakis, Paraskevaidis, Tsiga, Seferiadis, and Lolis (1996) was conducted
to see if combining pelvic examinations with serum CA-125 is an effective way to screen for
ovarian cancer in asymptomatic women. The study included 2,000 women ages 45 years or older
(mean of 58.1 years) and those with a history of cancer or current diagnosis of cancer, bilateral
oophorectomy, or ascites were excluded. The goal was to find a screening test for ovarian cancer
with high specificity to reduce unnecessary expensive and dangerous testing.
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All women in the study received both pelvic examination by gynecologists and
measurement of serum CA-125 (Adonakis et al., 1996). The pelvic examination was positive
when a mass was felt or if the bimanual exam was inadequate therefore the exam was considered
ambiguous. Women with either a positive bimanual pelvic examination, CA-125 levels above 34
U/ml or both were then evaluated by transvaginal ultrasound. The ultrasound was considered
positive if there was hyperechogenicity, hypoechogenicity, an irregular outline, or abnormal
volume. Those with a positive ultrasound went on for surgical exploration via laparoscopy or
laparotomy.
There were 174 women who had a positive bimanual examination and 18 had elevated
serum CA-125 levels (Adonakis et al., 1996). These women went on for additional screening
with transvaginal ultrasound and15 had further surgical exploration performed. Three cases of
malignancy were found: one case of a borderline tumor, one case of metastatic carcinoma, and
one case of ovarian cystadenocarcinoma. The other 12 women had abnormal pelvic exams from
benign adnexal masses or endometriosis.
This study using serum CA-125, bimanual pelvic examination, and transvaginal
ultrasound for ovarian cancer screening had 100 percent sensitivity, 99.7 percent specificity, and
positive predictive value of 22 percent revealing the combination screening is effective when
cost is not a factor (Adonakis et al., 1996). The authors discussed that any of these three
screening methods alone are ineffective. The pelvic examination alone for screening had a
sensitivity of 66.67 percent and specificity of 97.2 percent with a positive predictive value of
3.39 percent, only half of patients with early stage ovarian cancer have elevated serum CA-125
and levels can be elevated without disease, and the specificity of transvaginal screening alone is
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not effective. The sensitivity, specificity, and positive predictive value of each test and combined
can be seen in table 10. In this study, it was felt the false positives could not have been avoided.
One strength of this study was using all three screening methods. Most other studies do
not compare all of these. A limitation to this study is that it is over 10 years old and advances
have been made on ultrasound technology since and therefore, may have improved findings.
Also, similar to pelvic examinations, ultrasounds are technician and interpretation dependent and
results could vary from this.
Table 10
Specificity, Sensitivity and Positive Predictive Value

Pe1vic examination
CA-125
Pelvic examination
+ CA-125
Pelvic examination + CA·
125 + ultrasound

Specilicity

Sensiuvuy

P.P.V.

97.20%
99.25%
99.70%

66.67%
100%
100%

3.39%
16.67%
22.22%

99. 70'/o

100%

22.22%

Note: Adapted from “A combined approach for the early detection of ovarian cancer in
asymptomatic women”, by G. L. Adonakis, E. Paraskevaidis, S. Tsiga, K. Seferiadis, and D. E.
Lolis, 1996, European Journal of Obstetrics & Gynecology and Reproductive Biology, 65, p.
221-225. Copyright: 1996 by Elsevier Science Ireland Ltd.
The Prostate, Lung, Colorectal and Ovarian (PLCO) trial was a randomized control study
to determine the effect of ovarian cancer screening by transvaginal ultrasound and serum CA125 (Buys et al., 2011). The outcome measured in the trial was primarily mortality from ovarian
cancer and second, to determine the number of ovarian cancer cases and complications of false
positives in screening for ovarian cancer. There was a total of 78,216 women ages 55 to 74 years
who participated from November 1993 to July 2001. The women were randomly assigned to
either the control group who underwent usual care or the intervention group who had annual
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screenings with CA-125 levels for six years and transvaginal ultrasound for four years. This trial
was not a blind study because of the intrusiveness of the procedures. The women were then
followed for a maximum of 13 years to obtain new ovarian cancer diagnoses or death. All CA125 levels were evaluated in the same laboratory and the cutoff was 35 U/mL, anything above
was considered above normal limits (Buys et al., 2011). For the transvaginal ultrasounds, a 5 to
7.5 MHz probe was used, and a minimum of five minutes were spent on each screening. On
ultrasound, if an ovary or cyst was larger than 10 cm3 or had a projection into the tumor, the
result was abnormal.
This study diagnosed 212 women with ovarian cancer and 118 deaths in the intervention
group and 175 diagnoses with 100 deaths in the usual care group (Buys et al., 2011, p. 2295).
The most common grade of cancer diagnosed in each group was grade 3 or high grade. Cancer
diagnoses in this study can be seen in tables 11 and 12. A total of 4.2 percent or 3,285
participants had false positive screenings and 1,080 of these had surgical exploration with a 15
percent rate of serious complication from the surgery. The PLCO trial did not find that CA-125
screenings nor transvaginal ultrasounds reduced mortality from ovarian cancer even though both
have a higher sensitivity than bimanual ovarian palpation (Doroudi, Kramer, & Pinsky, 2016).
There was not a statistical difference in ovarian cancer screening with these methods on
mortality. The cases and mortality found in this study are demonstrated by graph in figure 13. It
was not found that cancer stages were less in the intervention group (stage shift was absent,
ovarian cancer staging was not statistically different).
This study also discussed harms caused by ovarian cancer screening (Buys et al., 2011).
Less severe complications that can come from transvaginal ultrasounds and CA-125
measurement are bleeding, bruising, nausea, and fainting. The serious complications include
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infection, cardiovascular or pulmonary events, injury from surgery, bowel trauma, and false
positive results. Approximately half of the participants in both groups had at least one major
complication from screening (Buys et al., 2011).
The trial did show a 35 percent reduction in mortality from ovarian cancer (p= 0.05)
which was not significant from a statistical standpoint, but from a public health standpoint, this
may be an important reduction to note (Buys et al., 2011). The relative risk was calculated to be
82 percent which means 18 percent may show benefit to decreasing ovarian cancer mortality by
these screening techniques. In addition, the PLCO trial did not choose surgeons or oncologists
for the ovarian cancer cases and different providers or treatment plans for ovarian cancer could
impact outcomes on mortality.
This study also discussed the possibility of lowering the CA-125 cutoff and size on
transvaginal ultrasound to detect ovarian cancer earlier, however, this may cause more false
positives leading to more unnecessary surgeries and complications (Buys et al., 2011).
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Table 11
Findings in Intervention Group Versus Usual Care Group
Usual
Intervention Care
Group
Group
(n = 212) (n = 176)
Cancer site

Primary invasive
neoplasm
of ovary
Primary
peritoneal
cancer
Primary invasive
neoplasm of

169 (00)

15 1 (86)

29(14)

18 (10)

14(7)

7 (4)

fallopian lube
Histology
Serous

116 (55)

MUCl')OUS

Endometrioid
Clear cell
Not specified
and other
Unknown

3 (2)

19(9)

8 (5)

6 (3)

6 (3)

66(31)

55 (31)

0

Grade
1

103 (59)

5 (2)

1 (1)

12(6)

7 (4)

2

29(14)

2 1 (12)

3

132 (62)

109 (62)

7 (3)

6(3)

Unknown

32(15)

33 (19)

Detection
Screening at
baseline

20(9)

NA

Screening
at 1-5 y

53(25)

NA

Interval cases0

37 (17)

NA

After screening
phase
(COfll)ianl)

78 (37)

NA

16(8)

NA

8 (4)

NA

Could not be
assessed

Never screened
(noncompliant)
During
screening
phase

After screering
phase

Abbr8Wllloo: NA, data no! "1)1)1:able.
8 SLl:loeCllon&dorot eqtal 100% booluleperoon1ageswere

b rounded to the neat'8St whde rurrt>er'.
Oeltled In the -Methods" sealon.

Note. Adapted from “Effect of screening on ovarian cancer mortality: The prostate, lung,
colorectal and ovarian (PLCO) cancer screening randomized control trial”, by S. S. Buys, E.
Partridge, A. Black, C. C. Johnson, L. Lamerato,…C. Berg. 2011, JAMA, 303(22), p. 2295-2303.
Copyright: 2011 by the American Medical Association.
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Table 12
Ovarian Cancer Cases Stages and Study Year
No. (%) of Women

Intervention Group

Usual Care Group

StudyYe.ar
0-5
(n .. 126)

CM::erstage
I

rv
Unknown

6-12
=86)

Total
(n .. 212)

13 (15)

32 (15)

(n

19 (15)

II
Ill

Study Year
(n

6-12
(n = 77)

0-5
=99)

5 (6)

18 (10)

46(46)

7 (9)
37 (48)

20 (11)
83 (47)

27 (27)

27 (35)

54 (31)

1 (1)

1 (1)

13 (13)

11 (9)

4 (5)

75 (60)

45 (52)

15 (7)
120 (57)

20 (16)
, (1)

23 (27)

43 (20)

1 (1)

2 (1)

Total
(n i : 176)

13 (13)

0

Note. Adapted from “Effect of screening on ovarian cancer mortality: The prostate, lung,
colorectal and ovarian (PLCO) cancer screening randomized control trial”, by S. S. Buys, E.
Partridge, A. Black, C. C. Johnson, L. Lamerato,…C. Berg. 2011, JAMA, 303(22), p. 2295-2303.
Copyright: 2011 by the American Medical Association.
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Figure 13. Ovarian Cancer Cases and Deaths in Intervention and Usual Care Groups
Note. Adapted from “Effect of screening on ovarian cancer mortality: The prostate, lung,
colorectal and ovarian (PLCO) cancer screening randomized control trial”, by S. S. Buys, E.
Partridge, A. Black, C. C. Johnson, L. Lamerato,…C. Berg. 2011, JAMA, 303(22), p. 2295-2303.
Copyright: 2011 by the American Medical Association.
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The University of Kentucky Ovarian Cancer Screening Project was conducted from 1987
to 1992 to determine the effectiveness of transvaginal ultrasounds for ovarian cancer screening in
postmenopausal asymptomatic women (DePriest, Van Nagell, Gallion, Shenson, Hunter,
Andrews, Powell, & Pavlik, 1993). There was a total of 3,220 asymptomatic, postmenopausal
women who participated in the study with no mention as to how the women were selected.
Women who were symptomatic, had a history of pelvic abnormality, or a history of ovarian
cancer were excluded from participating in the study. All women had a transvaginal ultrasound
performed. Ultrasound results were considered abnormal when the calculated ovarian volume
was greater than 10 cm3 or a papillary projection into a cystic ovarian tumor was found. If either
abnormality was found on ultrasound, the ultrasound was repeated four to six weeks later. If the
second ultrasound was again abnormal, the women had CA-125 serum levels drawn and a rating
was given to each tumor found. Then, women with repeated abnormal ultrasounds underwent
pelvic examination and surgery for further investigation.
Out of the 3,220 women, 44 had abnormal ultrasounds and underwent surgery. Of these
44, three were found to have ovarian cancer (two of them being stage IA and one being stage
IIIB) and 21 were found to have serous cystadenomas (DePriest et. Al., 1993). Interestingly, all
three of the ovarian cancer cases found during this study had normal pelvic examinations and
normal CA-125 serum levels. In addition, 24 out of the 44 women (55%) with abnormal
ultrasounds had a significant finding with surgery even though most were benign serous
cystadenomas, these do have the potential to become malignant and may be important to find
early. Therefore, this study found that transvaginal ultrasounds could be an effective way to
screen for ovarian cancer, but a larger study should be performed.
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One large limitation to performing transvaginal ultrasounds for screening is that it cannot
determine the difference between benign and cancerous tumors. However, it was found during
this study that all the benign tumors had an ultrasound morphology index less than five which
may be an effective method. Also, the technology of ultrasound since publication of this study
has improved significantly and with CA-125 screenings, may be a potential for ovarian cancer
screening.
Another University of Kentucky Ovarian Cancer Screening Project began in 1987 and
ended in 2005 to determine how effective transvaginal ultrasounds are for screening for ovarian
cancer (Van Nagell, DePriest, Ueland, DeSimone, Cooper, McDonald, Pavlik, & Kryscio, 2007).
Only asymptomatic women were included in the study, and participants either had to be 25 years
or younger with a family history of ovarian cancer or 50 years old or older without family
history. Women were excluded from the study if they were symptomatic or had a personal
history of ovarian cancer or tumor. A group of 25,327 women received transvaginal ultrasounds
(TVU) to measure ovarian size based on a standardized calculation. Ultrasounds were considered
abnormal if the ovarian volume was calculated to be greater than 20 cm3 in premenopausal
women, greater than 10 cm3 in postmenopausal women, or any tumor found with projection.
Women with normal ultrasounds were instructed to repeat the ultrasound in 12 months, and
women with abnormal ultrasounds were instructed to follow up in four to six weeks for a repeat
transvaginal ultrasound. If the second screening was abnormal, these women underwent further
testing including CA-125 levels and further imaging. If the tumor measured less than or equal to
five cm and the women had normal CA-125, these women were followed every six months. If
the tumor was larger than five cm or elevated CA-125, they had surgery for further exploration.
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The mean age of the population of the women in the study was 56 years old, mean parity
was 2.4 with 14.6 percent being nulliparous, and mean weight was 72.21 kg (Van Nagell et al.,
2007). There were 120,569 total transvaginal ultrasounds performed throughout this study with
an average of 4.8 ultrasounds per woman. 364 women had ovarian tumors that did not resolve
after further examination and had surgery.
The majority of tumors found during surgery were benign findings including serous
cystadenomas (153 women) and endometriomas (30 women) (Van Nagell et al., 2007).
However, the second most commonly diagnosed tumor was primary ovarian cancer in 44
women. Of the 44 diagnoses, 28 were stage I, seven were stage II, and eight were stage III.
Borderline cancer was found in nine women. Four of the 44 women diagnosed with ovarian
cancer have passed away, and the remainder had still been alive at the publication of this study.
There were nine cases of false negative screenings where these women were diagnosed
with ovarian cancer within one year after a negative transvaginal ultrasound reading and three of
these cases passed between 0.7 and 7.0 years after their cancer was found (Van Nagell et al.,
2007). It was interestingly found from this study that women with a family history of ovarian
cancer did not have higher rates of ovarian cancer or tumors found.
Based on these results, this study had calculated that using transvaginal ultrasounds for
ovarian cancer screening had a positive predictive value of 0.1401 for finding abnormal results
and the negative predictive value was 0.999 (Van Nagell et al., 2007). Positive predictive value
actually increased during the study from 8.8 percent during the years 1987 to 2000 to 27.1
percent during 2001 to 2006 due to changing the screening methods. In 2001, the study was
changed for tumors under or equal to five centimeters and instead of undergoing surgical
exploration right away, these women were followed every six months by transvaginal ultrasound,
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and this improved screening methods. The sensitivity was found to be 85 percent and the
specificity was found to be 98.7 percent. There were 313 false positive patients who underwent
surgery which resulted in benign findings. Interestingly, the group who had annual screenings
and diagnosed with ovarian cancer had a 92.1 percent two-year survival rate in comparison with
the general population with unknown screenings and possibly no screening had a two-year
survival rate of 70.7 percent.
Overall through this study, it was found that transvaginal ultrasounds are safe, have a
relatively low cost, relatively comfortable for patients, and takes only about five to 10 minutes to
complete (Van Nagell et al., 2007). One limitation is medical professionals can read ultrasound
results incorrectly or ultrasound technicians can perform them incorrectly. Another limitation to
using TVU for ovarian cancer screening includes a low positive predictive value and less than
ideal sensitivity. There was a significantly high number of false negatives (nine) due to normal
TVU results who did not go on to have CA-125 read because this was only performed if the
ultrasound was abnormal. CA-125 was performed prior to surgery in these nine false negative
groups and eight of them had elevated markers. Therefore, possibly screening with CA-125 with
ultrasound is worth considering. However, it was noted that in 13 of the 15 women with stage III
cancer had elevated CA-125 levels but only three of the 15 with stage I or II cancer had elevated
CA-125 possibly meaning that screening to detect ovarian cancer in the early stages may not be
effective.
The low positive predictive value is problematic in screening for ovarian cancer because
the transvaginal ultrasound cannot determine the difference between cancerous tumors and
benign tumors which would lead to additional procedures, cost, and surgeries. That is why study
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criteria changed in 2001 and only followed women closely with tumors that were five
centimeters or smaller instead of surgery right away.
Even with a low positive predictive value, this study showed that TVU screenings were
effective at diagnosing ovarian cancer sooner when compared to those without regular screenings
(Van Nagell et al., 2007). In this study, 82 percent of the women participating with ovarian
cancer were found in stage I or stage II compared to the general population of women diagnosed
with stage I or II being 34 percent. The study suggested possibly increasing screenings to more
than just annually in high risk populations or using genetic data to screen based on genetic risk.
A study published in 2014 was performed to determine how effective 2-dimensional (2D)
and 3-dimensional (3D) contrast-enhanced sonography is at finding small adnexal masses and
determining if the masses are benign or cancerous (Hu, Xiang, Feng, Gu, & Liu, 2014). This
study was performed between June 2009 and June 2012 at the First Affiliated Hospital of
Xinjiang Medical University. There was not a control group in this study. Women were included
in this study if they were found by conventional 2D ultrasound to have an adnexal mass of
unknown malignancy estimated to be smaller than four cm. Women were excluded from this
study if they were allergic to contrast dye, pregnant or breastfeeding, had renal disease or severe
medication allergies, or younger than 18 years old. Women were included if they had a history of
ovarian cancer which is opposite of most studies reviewed. A total of 57 women participated in
this study and underwent further examination of their masses by 3D and 3D contrast-enhanced
transvaginal ultrasound and then went on for surgical exploration. The results found by
ultrasound were compared to results found in surgery. In the 57 women, 10 were found to have a
malignant tumor and 47 had benign masses by ultrasound and verified by surgery. There was a
significant difference found between the benign and malignant tumors on the 2D and 3D
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contrast-enhanced ultrasound studies (p < 0.05). When using both 2D and 3D ultrasound with
contrast in evaluating adnexal masses, it is calculated that sensitivity was 100 percent, but the
specificity was less than ideal at 62.75 percent and a positive predictive value of 36.55 percent. It
was noticed during this study that perfusion in the masses helped determine whether the mass
was benign or malignant and malignant masses had “fine intracystic septa and a smaller nipple in
the interior” (Hu, Xiang, Feng, Gu, & Liu, 2014, p. 1896).
A strength of this study is that all ultrasounds were performed on the same machine and
the contrast agent used was the same for all patients which was the “sulfur hexafluoride
microbubble agent- SonoVue” (Hu, Xiang, Feng, Gu, & Liu, 2014, p. 1896). A benefit to using
a contrast agent with ultrasound is that the agent follows into microcirculation of the masses and
can be seen on the ultrasound whereas standard color doppler ultrasound does not have
sensitivity to pick up blood flow in a mass.
There were several cases that were difficult to interpret the difference between benign
and malignant on ultrasound which authors recommended a more specific test is needed, which
has not been discovered yet (Hu, Xiang, Feng, Gu, & Liu, 2014). Also, professionals reading the
ultrasounds may not be as experienced in reading these advanced contrast studies in comparison
to the traditional ultrasound performed. In addition, ultrasound is not a standardized test and
technician errors can be made. This study included a very small population sample; therefore, a
larger scale study would be worth performing based on the positive results of this test. This study
demonstrated that 2D and 3D ultrasounds with contrast are an important consideration to
perform in women with undetermined adnexal masses before performing a possibly unnecessary
surgery. Ultrasound is relatively less expensive and safer than surgery for further evaluation of
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adnexal masses. However, there may be unwanted risks from the contrast agent to be used as a
screening test for ovarian cancer.
A study was conducted in the Shizuoka district of Japan between 1985 and 1999 to
determine if ovarian cancer can be detected earlier with annual screenings using transvaginal
ultrasound and serum CA-125 levels (Kobayashi et al., 2008). This was a randomized controlled
study where post-menopausal women were randomly selected for either a control group which
contained 40,799 women and an intervention group of 41,688 women and were followed for an
average of 9.2 years. The intervention group included annual pelvic ultrasounds and serum CA125 measurement and if either or both were found to be abnormal, the women went on for
surgical exploration. Of the intervention group, 27 cancers were diagnosed during the screening
time and the detection rate was calculated to be 0.31 cases out of 1,000 women at initial
screening and 0.38-0.74 cases out of 1,000 women at following screenings. From the control
group without regular screenings, 32 women were found to have ovarian cancer. It was found
that more stage I cancers were found in the intervention group in comparison to the control
group, however this was not statistically significant (p = 0.2285). Therefore, it is recommended
further evaluation and study be performed. The false positives of this study were nine percent
which leads to additional unnecessary surgery and anxiety for women.
It is encouraging that this study included only asymptomatic post-menopausal women
and excluded women from the study if they had a history of bilateral oophorectomy or prior
history of cancer (Kobayashi et al., 2008). However, it is important to note that costs and
incidences of false positives would be increased in a premenopausal group because there should
be less cases found of ovarian cancer compared to a post-menopausal group (Kobayashi et al.,
2008). A few strengths of this study include using a standardized automatic machine to measure
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CA-125 markers, the median age of both the control and intervention group women was the
same at 58 years, all records and results from the study were secondarily reviewed by examiners,
any cases of death throughout the study were investigated by medical records and autopsy, and
any participant who no longer participated in the study before it ended were searched for in a
death database.
There are several limitations to this study as well. One limitation is prior to 1990, most of
the ultrasounds were performed transabdominally which is not as sensitive as a transvaginal
ultrasound in detecting ovarian masses (Kobayashi et al., 2008). Another is medical history was
obtained by in person interviews and not a review of the medical record which is not ideal
because some medical history can be forgotten or forged. This study only included one district in
Japan and results could vary between other districts or countries. Also, the dropout participation
rate over the years of the study was shocking due to moving or no longer wanting to participate;
by the fifth year of participation, 56 percent of women were still in the study.
The UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) was performed
from 2001 to 2005 to determine the effectiveness of screening for ovarian cancer on mortality
and is the largest controlled trial for ovarian cancer (Menon et al., 2009). This was a randomized
controlled trial where post-menopausal women ages 50 to 74 from 13 different locations across
England were included. Women were randomly assigned to one of three groups in a 2:1:1
division method. The first group was 101,359 women who received no treatment. The second
group was 50,640 women who received CA-125 screenings annually followed by a transvaginal
ultrasound. The third group was 50,639 women who received only an annual transvaginal
ultrasound. If any of the screening methods were abnormal, the testing was repeated. If the
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second test was abnormal, then the women went on for further evaluation and surgery if
necessary.
Combining both the transvaginal ultrasound and serum CA-125 for ovarian cancer
screening had a sensitivity of 89.4 percent, specificity of 99.8 percent, and positive predictive
value of 43.3 percent in comparison to screening with transvaginal ultrasound alone with a
sensitivity of 84.9 percent, specificity of 98.2 percent, and positive predictive value of 5.3
percent (Menon et al., 2009). Therefore, this study had found that CA-125 screening with
transvaginal ultrasound had very optimistic sensitivity and authors discussed that results from
this study indicate that these are effective screening methods when combined. However, two
points to consider is that this study was performed in England and it cannot be assumed results
can be generalized to the US, and secondly England has a universal health system which ovarian
cancer screening may save money in the long run for a public health system but may not be cost
effective in the US for insurance companies. It has been found that cases of ovarian cancer in the
UK is one out of 1,000 women, whereas in other countries this can be one in 78 women which is
vastly different.
Several strengths to this study include women were followed closely after the study to
monitor for false negative cases (13 were found the next year), all the surgical cases were
independently reviewed, and serum CA-125 screening is a standardized lab making error rare
(Menon et al., 2009). Another strength is that all women who participated were marked in the
UK’s electronic health system so that the study would get notifications on each participant even
after the study ended. A limitation to this study is that transvaginal ultrasound results are very
dependent on the ultrasound technician and the healthcare professional interpreting the scan, and,
therefore, this specific study had all the ultrasound technicians perform regular training, have
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regular audits, and adjust to constructive feedback to minimize error. Another limitation to this
study is that there is not any information from the control group regarding cancer diagnoses.
Discussion
Bimanual Pelvic Examination for Ovarian Cancer Screening
There are several different organizations who have provided advice or recommendations
on whether pelvic examinations should be performed on a regular basis in asymptomatic women
for gynecological screening. The U.S. Preventive Services Task Force (USPSTF) feels that there
is not enough evidence to be for or against routine screening and are unsure of the benefits
versus the harms because of the lack of studies (USPSTF, 2017). Therefore, the USPSTF has not
given a recommendation for pelvic examination screening with a Grade I for insufficient
evidence. The American College of Physicians (ACP) released new guidelines in 2014 and
recommend not performing regular pelvic examination screenings in asymptomatic women
based on a systematic review of over 50 years of research (Qaseem, Humphrey, Harris, Starkey,
& Denberg, 2014). This guideline is a strong recommendation based on moderate quality
evidence, which is not ideal evidence for guidelines. Also, many of the studies used for the ACP
recommendation are well over ten years old; three of the studies were from the 1970’s, and many
more from the 1980’s and 1990’s which is interesting that the recommendation just changed
within the last 10 years to not perform pelvic examinations and yet most the evidence is much
older than the new recommendation (Qaseem, Humphrey, Harris, Starkey, & Denberg, 2014). In
addition to low sensitivity, the ACP believes cost, false sense of security, unnecessary further
testing, and increased anxiety are other reasons why pelvic exams should not be performed. The
American Academy of Family Physicians (AAFP) also recommends against performing pelvic
examination screenings in asymptomatic women giving a Grade D recommendation due to
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evidence of little benefit and possible harm (AAFP, 2017). The ACOG recommends annual
pelvic exams at well-woman visits (ACOG, 2016). The College states this guideline was made
by expert opinion. They state that, in addition, there should be a discussion between patient and
provider to come to a shared decision prior to a pelvic examination. Without strong evidence to
support or discourage routine pelvic exams in asymptomatic women, expert opinion is needed.
Furthermore, without strong evidence either way, discussion of available evidence and shared
decision making between provider and patient would be logical.
The research on whether bimanual pelvic examinations should or should not be
performed for ovarian cancer screening does not lead to an easy answer. A screening test for
ovarian cancer would ideally have a higher sensitivity rate to detect true positives than what is
found with bimanual pelvic examination. For example, the PLCO trial and several other studies
found that bimanual palpation has low sensitivity for ovarian cancer screening which leads to a
high false positive rate causing additional testing, anxiety, cost, and possibly surgery. Grover and
Quinn (1995) found that 20 percent of women would undergo surgery for benign findings from
pelvic exams and therefore do not recommend routine pelvic examinations for ovarian cancer
screening nor as part of a well-woman visit.
Steolinga et al. (2014) conducted their research on estimating fibroid uterine volume and
found that bimanual examinations are poor at estimating uterine size when the uterus is between
233 and 747 grams (providers tended to underestimate size) and better at estimating size when
the uterus was smaller than 233 grams or larger than 747 grams. In application to this specific
literature review, this study did not evaluate adnexal masses; however, the information found in
this study is important to take note.
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Even though many studies show bimanual exams have low sensitivity which is not ideal
for screening, some researchers believe pelvic examinations should be considered and most
providers tend to agree as well. Abenhaim, Titus-Ernstoff, and Cramer (2007) through their
research found that women who do not have annual pelvic examinations, medical visits, or a
regular healthcare provider are at an increased risk of ovarian cancer and therefore, pelvic
examinations are recommended in addition to regular medical visits. Padilla, Radosevich, and
Milad (2000) by conducting their research of bimanual examinations under ideal circumstances
with the women under general anesthesia in the lithotomy position, bladders emptied via Foley
catheters, and the providers not knowing why the patients were having surgery, found that
sensitivity is low and adnexal masses are found only eight percent of the time. However, the
researchers do not advise to not perform pelvic exams but rather just to know the limitations.
Current evidence is not strong enough and is outdated to not perform pelvic
examinations. Ovarian cancer is usually detected late with a low five-year survival prognosis,
and if the bimanual exam may find some of these cases early, it is worth performing. There is a
high benign findings rate which can lead to additional cost, testing, anxiety, and possibly
unnecessary surgery, however, these are necessary to find some cases of ovarian cancer early.
Due to Abenhaim, Titus-Ernstoff, and Cramer (2007) research, women should also have annual
well-woman visits with their regular healthcare provider in addition to the annual pelvic exam to
reduce their ovarian cancer risk.
Beliefs and Practices of Bimanual Pelvic Examinations
All studies reviewed that were conducted to evaluate provider’s practices and beliefs
show that the majority of providers, especially gynecologists and obstetricians, still feel
bimanual pelvic examinations are an important part of the well-woman visit. For example,
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Henderson et al. (2013) found that when providers are presented with four cases where women
are not in need of a Pap, most thought a pelvic examination should be performed, even on the
patient with a bilateral oophorectomy and hysterectomy. Another study conducted by Henderson,
Yu, Harper, and Sawaya (2014) found that almost all providers feel that annual pelvic
examinations are very important or moderately important. However, over three quarters of
providers who participated in these two studies lead by Henderson belong to the American
College of Obstetricians and Gynecologists (ACOG), which has different recommendations from
ACP regarding pelvic exams. Stewart, Thistlethwaite, and Evans (2008) also found that
providers continue to perform regular pelvic examinations even though ACP guidelines advise
not to.
Stormo, Cooper, Hawkins, and Saraiya (2012) studied internal medicine and family
medicine providers as well as obstetricians and gynecologists and obtained the same results that
the majority feel pelvic exams are useful for screening. However, most obstetricians and
gynecologists and family practitioners felt that bimanual exams should be performed for ovarian
cancer screening but only approximately 30 percent of internal medicine providers felt this way.
Another study led by Stormo found that nearly all obstetricians and gynecologists and family
medicine providers and just over half of internists feel that pelvic exams should be routinely
performed in well-woman exams (Stormo, Hawkins, Cooper, & Saraiya, 2011). Ovarian cancer
screening was one of the top reasons provided to perform them in asymptomatic women.
The research conducted by Kling et al. (2017), regarding women’s beliefs on pelvic
examinations before and after the new ACP guidelines, found that the majority of women have
regular pelvic exams performed and want to continue doing so even after learning the new ACP
guidelines recommending to not have them performed when asymptomatic. Also, women, in
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general, do not feel as uncomfortable or pain during a pelvic exam as many tend to believe
(Qaseem, Humphrey, Harris, Starkey, & Denberg, 2014). Those who find them more
uncomfortable tended to be overweight or obese women or those with a sexual abuse history.
In practice most providers continue, based on their own expertise, to continue performing
annual bimanual pelvic exams in asymptomatic women even though most guidelines recommend
against it or remain neutral. Most female patients as well would like to continue having pelvic
examinations performed even after being given the new ACP guidelines.
Other Ovarian Cancer Screening Methods
Since the bimanual pelvic exam has low sensitivity for ovarian cancer screening, there
has been much research to find an alternative test. After performing a literature review, there
does not seem to be one perfect test for ovarian cancer screening. Therefore, researchers continue
to look for ideal screening tests. DePriest et al. (1993) found that transvaginal ultrasound alone is
beneficial in ovarian cancer screening, but it was a small population studied and it was
recommended that a larger study be conducted. Van Nagell et al. (2007) found that annual
screening with transvaginal ultrasound detected ovarian cancer in earlier stages and had a higher
two-year survival rate then compared to the general population.
However, combining different screening methods for ovarian cancer has proven to be
effective. The most promising study was by Adonakis et al. (1996) due to its almost perfect
sensitivity and specificity when combining serum CA-125 with bimanual pelvic examination
annually and if either or both was positive, then further investigation was performed by
transvaginal ultrasound. The PLCO trial did show a 35 percent reduction in mortality from
ovarian cancer when screening with annual transvaginal ultrasound and serum CA-125, which
was not significant from a statistical standpoint, but important to note that there was a reduction
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in mortality (Buys et al., 2011). The UKCTOCS was the largest controlled trial for ovarian
cancer screening that proved to be successful with a high sensitivity by screening with both
serum CA-125 and transvaginal ultrasound annually (Menon et al., 2009). Kobayashi et al.
(2008) found that annual screening with both transvaginal ultrasound and CA-125 resulted in
earlier ovarian cancer diagnoses at stage I rather than later stages, however, the results were not
statistically significant.
Regarding ultrasounds, 2D and 3D enhanced contrast sonography are important to
consider in screening because the research by Hu, Xiang, Feng, Gu, and Liu (2014) had positive
outcomes being able to differentiate benign from malignant masses. Ultrasound with contrast
may be an important consideration to perform in women with undetermined adnexal masses
before performing a possibly unnecessary surgery because the mass can be better visualized with
the contrast.
Based on this research, serum CA-125 and transvaginal ultrasounds are better methods to
screen for ovarian cancer than the bimanual exam. However, cost was not considered in any of
the studies which may be a limiting factor and important to note. Further research should be
conducted on serum CA-125 and transvaginal ultrasounds to determine if both should be offered
annually to the average risk asymptomatic adult female population for ovarian cancer screening.
Also, insurance companies would need to begin covering CA-125 and transvaginal ultrasounds
for ovarian cancer screening if research supports this. Ovarian cancer is a deadly diagnosis due to
usually finding it late in disease and research shows these two tests may be promising to find
cases sooner.
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Application to Clinical Practice
After reviewing the studies and data, a discussion should be had between an
asymptomatic woman and provider on the potential risks and benefits of performing bimanual
pelvic examinations. It should be a combined decision and addressed annually. Each woman
should be treated as their own individual with all their factors taken into account in the
decision making. It should not be assumed that bimanual exams do not need to be performed
anymore nor that they should be performed annually without discussion. If a woman does not
wish to decide or would like professional advice, based on common practice of expert providers,
it should be advised to perform them annually. There are not any other screening tests covered
by insurance for ovarian cancer screening and, therefore, pelvic examinations will low sensitivity
will have to suffice until further studies, research, or guidelines.
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RESEARCH AND STATISTICAL DATA REVIEW REFLECTION
On November 20, 2018, I met with Carrie Tirel, Ph.D., professor of mathematics, at the
University of Wisconsin- Fox Valley to discuss the data and statistics in my scholarly project. I
originally sent her my project with certain sections and data highlighted with questions. Then, we
sat down to discuss the project and questions together. She found the information very
interesting and enjoyed helping with the project. She thought that I had high quality research
with a sufficient amount of data. She explained to me different terms and calculations that I
found in numerous articles that I did not understand, for example, the Youden’s J statistic. She
also did manual calculations and corrected some original statistics that were in my paper. She
helped me use p values and confidence intervals properly in my research project because I had
originally not understood how to state them. Ms. Tirel helped explain sensitivity, specificity, and
positive predictive value in a way that I have not seen before and wrote it out for me to keep. In
addition, she explained several graphs, that all had the same concept with adjusted odds ratios,
but I was not understanding the calculations and meanings of them until her explanation. Overall,
I found our meeting extremely helpful.
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INTERDISCIPLINARY MEETING REFLECTION
In December 2018, I met with Stephanie Gold, DO in family medicine, at Ripon Medical
Center. We discussed the topic of this scholarly project which is determining the importance of
bimanual pelvic examinations for ovarian cancer screenings, beliefs regarding pelvic exams, and
additional ovarian cancer screening options. Being the primary female provider at this facility,
she cares for most of the female population and has much experience with women’s health,
especially because there is not an obstetrician or gynecologist at this rural clinic.
Since reviewing this research, she has been a bit confused as to what to perform in her
own practice regarding pelvic examinations. She finds it frustrating that the guidelines and data
are conflicting and there is not a straightforward guideline as there is for breast cancer screening
or cervical cancer screening. Since reading the literature, she has been having a discussion with
her female patients and offering bimanual exams more often.
Dr. Glod brought up a few more thoughts in our discussion. She wonders if there will be
negative consequences seen in the near future with female genitalia by performing Paps every
three years instead of annually. She also wonders what the data shows regarding other reasons to
perform bimanual exams and visual inspections such as vulvar cancer, STDs, etc. Quite possibly
there may be better reasons to perform bimanual exams than only for ovarian cancer screening.
Overall, she really enjoyed reading the scholarly project. She thought that it included
good content. She liked that I looked at different perspectives including studies on ovarian
cancer screening, providers’ perspectives, and women’s perspectives. She also enjoyed reading
the literature review, in particular the strengths and limitations of each study.
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WRITING CENTER MEETING REFLECTION
On January 16, 2019, I discussed my scholarly project with Jen from the UND Writing
Center over the phone. She was able to help me with some editing, citation, and formatting.
She read through several of the pages of the project out loud with me and corrected a few
editing errors. She helped a few sentences flow better and gave feedback on wording and
terminology.
I was really hoping for feedback on my APA citation and works cited page, but no
feedback or suggestions were made because she does not know APA citation, and usually works
with MLA. I asked a specific question regarding citation of charts and graphs, and she did try
looking up the answer. However, looking up the answer took a good part of my appointment slot.
Therefore, I did ask for general feedback on APA formatting, but did not ask any more specific
questions due to time. I did not get any feedback on APA citation.
I feel this would have been more beneficial if the writing center staff member looked at
the project before meeting. Her first look at my paper was at the beginning of the meeting and a
60-page paper cannot be reviewed in one hour. I wish she had glanced at it before the meeting,
and then the meeting could have been all feedback, especially because I am nearly completed
with my project.
Overall, after looking at a few pages, she thought the project is well written. She also felt
she could understand and follow most of the paper even without a medical background. We
discussed the form that needs to be signed for proof of the discussion and she said I can email it
to the writing center and then will get a signature to return to me for submission.
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